Published in Neuropsychopharmacology on August 01, 2001
Morphine deprivation increases self-administration of the fast- and short-acting mu-opioid receptor agonist remifentanil in the rat. J Pharmacol Exp Ther (2008) 1.01
Opioid use affects antioxidant activity and purine metabolism: preliminary results. Hum Psychopharmacol (2009) 0.96
Cognitive function during early abstinence from opioid dependence: a comparison to age, gender, and verbal intelligence matched controls. BMC Psychiatry (2006) 0.96
Sex and opioid maintenance dose influence response to naloxone in opioid-dependent humans: a retrospective analysis. Pharmacol Biochem Behav (2008) 0.82
Electroacupuncture treatment normalized sleep disturbance in morphine withdrawal rats. Evid Based Complement Alternat Med (2011) 0.77
Dopaminergic terminals in the rat cortex. Science (1973) 1.73
Possible involvement of epinephrine in the cardiovascular effect of naloxone in humans. Clin Ther (1985) 1.62
Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects. J Pharmacol Exp Ther (2000) 1.56
Neural substrates of opiate withdrawal. Trends Neurosci (1992) 1.52
Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. J Pharmacol Exp Ther (1994) 1.35
Opponent process theory of motivation: neurobiological evidence from studies of opiate dependence. Neurosci Biobehav Rev (1989) 1.33
Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J Pharmacol Exp Ther (1992) 1.29
Some evidence for the existence of dopaminergic neurons in the rat cortex. Brain Res (1973) 1.26
Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat. Eur J Pharmacol (1994) 1.26
The effects of 6-hydroxydopamine lesions of the nucleus accumbens and the mesolimbic dopamine system on oral self-administration of ethanol in the rat. Brain Res (1993) 1.14
Relationship between the locomotor hyperactivity induced by A10 lesions and the destruction of the fronto-cortical dopaminergic innervation in the rat. Brain Res (1978) 1.13
Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine. Neuroscience (1995) 1.11
Chronic morphine exposure and spontaneous withdrawal are associated with modifications of dopamine receptor and neuropeptide gene expression in the rat striatum. Eur J Neurosci (1999) 1.10
Corticotropin-releasing factor induces a place aversion independent of its neuroendocrine role. Brain Res (1992) 1.08
D-amphetamine-induced behavioral sensitization: implication of a glutamatergic medial prefrontal cortex-ventral tegmental area innervation. Neuroscience (1999) 1.08
Central administration of a CRF antagonist blocks the development of stress-induced behavioral sensitization. Brain Res (1990) 0.98
Social deprivation enhances the vulnerability of male Wistar rats to stressor- and amphetamine-induced behavioral sensitization. Psychopharmacology (Berl) (1995) 0.98
Clonidine blocks acquisition but not expression of conditioned opiate withdrawal in rats. Neuropsychopharmacology (1998) 0.97
Radiofrequency lesion of the ventral mesencephalic tegmentum: neurological and behavioral considerations. Exp Neurol (1976) 0.94
Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal. J Pharmacol Exp Ther (1999) 0.93
Interactions between D-ala-met-enkephalin, A10 dopaminergic neurones, and spontaneous behaviour in the rat. Behav Brain Res (1980) 0.91
Behavioral sensitization to amphetamine is dependent on corticosteroid receptor activation. Brain Res (1989) 0.91
Locomotor activation induced by infusion of endorphins into the ventral tegmental area: evidence for opiate-dopamine interactions. Proc Natl Acad Sci U S A (1980) 0.91
Disappearance of hoarding behavior after 6-hydroxydopamine lesions of the mesolimbic dopamine neurons and its reinstatement with L-dopa. Behav Neurosci (1985) 0.91
Hyperactivity and hypoactivity produced by lesions to the mesolimbic dopamine system. Behav Brain Res (1981) 0.90
D-amphetamine-induced behavioral sensitization: effect of lesioning dopaminergic terminals in the medial prefrontal cortex, the amygdala and the entorhinal cortex. Neuroscience (2002) 0.90
Aversive properties of opiate receptor blockade: evidence for exclusively central mediation in naive and morphine-dependent rats. Brain Res (1988) 0.90
Central administration of corticotropin releasing factor induces long-term sensitization to D-amphetamine. Brain Res (1993) 0.89
Real-time sleep-wake scoring in the rat using a single EEG channel. Sleep (1994) 0.89
Increased spontaneous activity following substance P infusion into A10 dopaminergic area. Nature (1978) 0.89
Idazoxan and 8-OH-DPAT modify the behavioral effects induced by either NA, or 5-HT, or dual NA/5-HT reuptake inhibition in the rat forced swimming test. Neuropsychopharmacology (2001) 0.88
Small doses of apomorphine and chronic administration of d-amphetamine reduce locomotor hyperactivity produced by radiofrequency lesions of dopaminergic A10 neurons area. Biol Psychiatry (1977) 0.87
Opposite change of in vivo dopamine release in the rat nucleus accumbens and striatum that follows electrical stimulation of dorsal raphe nucleus: role of 5-HT3 receptors. J Neurosci (1998) 0.87
Anatomical relationships between the ventral mesencephalic tegmentum--a 10 region and the locus coeruleus as demonstrated by anterograde and retrograde tracing techniques. J Neural Transm (1979) 0.87
Evidence for selective involvement of dopamine D1 receptors of the ventral tegmental area in the behavioral sensitization induced by intra-ventral tegmental area injections of D-amphetamine. J Pharmacol Exp Ther (1996) 0.87
Biphasic effect on nociception and antiopiate activity of the neuropeptide FF (FLFQPQRFamide) in the rat. Peptides (1994) 0.86
Repeated stress increases locomotor response to amphetamine. Psychopharmacology (Berl) (1984) 0.86
Acute and chronic amphetamine treatments differently regulate neuropeptide messenger RNA levels and Fos immunoreactivity in rat striatal neurons. Neuroscience (1995) 0.86
Effect of peptidyl-dipeptidase inhibitors in experimental convulsions in mice. Fundam Clin Pharmacol (1987) 0.86
Substance P, neurotensin and enkephalin injections into the ventral tegmental area: comparative study on dopamine turnover in several forebrain structures. Brain Res (1989) 0.85
Behavioral effects of a lesion in the ventral mesencephalic tegmentum: evidence for involvement of A10 dopaminergic neurons. Adv Biochem Psychopharmacol (1977) 0.85
Substance dependence as a compulsive behavior. J Psychopharmacol (1998) 0.85
Reactivity and plasticity in the amygdala nuclei during opiate withdrawal conditioning: differential expression of c-fos and arc immediate early genes. Neuroscience (2008) 0.85
Critical role of the hypothalamic pituitary adrenal axis in amphetamine-induced sensitization of behavior. Life Sci (1990) 0.84
Effects of SCH 23390, raclopride, and haloperidol on morphine withdrawal-induced aggression in male mice. Pharmacol Biochem Behav (1999) 0.84
Effects of morphine and naloxone on behaviour in the hot plate test: an ethopharmacological study in the rat. Psychopharmacology (Berl) (1994) 0.83
The distribution of the projection from the parataenial nucleus of the thalamus to the nucleus accumbens in the rat: an autoradiographic study. Exp Brain Res (1984) 0.83
Increased sensitivity to (+)amphetamine self-administered by rats following meso-cortico-limbic dopamine neurone destruction. Nature (1979) 0.83
Differential mechanisms in the acquisition and expression of heroin-induced place preference. Psychopharmacology (Berl) (1989) 0.83
Interaction between neuropeptide FF and opioids in the ventral tegmental area in the behavioral response to novelty. Neuroscience (2002) 0.82
Discovery of the mesocortical dopaminergic system: some pharmacological and functional characteristics. Adv Biochem Psychopharmacol (1977) 0.82
Implication of beta 1- and beta 2-adrenergic receptors in the antinociceptive effect of tricyclic antidepressants. Eur Neuropsychopharmacol (1997) 0.82
Ethopharmacological analysis of naloxone-precipitated morphine withdrawal syndrome in rats: a newly-developed "etho-score". Psychopharmacology (Berl) (1995) 0.82
Effect of injections of 6-OHDA into either nucleus accumbens septi or frontal cortex on spontaneous and drug-induced activity. Neuropharmacology (1983) 0.82
A non-invasive gating device for continuous drug delivery that allows control over the timing and duration of spontaneous opiate withdrawal. J Neurosci Methods (2004) 0.81
The cytology of dopaminergic and nondopaminergic neurons in the substantia nigra and ventral tegmental area of the rat: a light- and electron-microscopic study. Neuroscience (1983) 0.81
Short and long-term changes in dopamine and serotonin receptor binding sites in amphetamine-sensitized rats: a quantitative autoradiographic study. Brain Res (1995) 0.81
Ventral tegmental area infusion of substance P, neurotensin and enkephalin: differential effects on feeding behavior. Neuroscience (1986) 0.81
[The analgesic activity of TRH and MSH]. Arch Farmacol Toxicol (1978) 0.81
Role of imidazoline receptors in the anti-aversive properties of clonidine during opiate withdrawal in rats. Eur J Neurosci (2005) 0.81
Behavioural activation induced in the rat by substance P infusion into ventral tegmental area: implication of dopaminergic A10 neurones. Neurosci Lett (1979) 0.80
Amphetamine-induced conditioned activity in rats: comparison with novelty-induced activity and role of the basolateral amygdala. Behav Neurosci (1995) 0.79
GABAergic mechanisms within the ventral tegmental area: involvement of dopaminergic (A 10) and non-dopaminergic neurones. Psychopharmacology (Berl) (1982) 0.79
Neurotensin, substance P, neurokinin-alpha, and enkephalin: injection into ventral tegmental area in the rat produces differential effects on operant responding. Psychopharmacology (Berl) (1989) 0.79
Mapping of c-fos gene expression in the brain during morphine dependence and precipitated withdrawal, and phenotypic identification of the striatal neurons involved. Eur J Neurosci (2000) 0.79
Chronic neuroleptic treatment and mesolimbic dopamine denervation induce behavioural supersensitivity to opiates. Psychopharmacology (Berl) (1985) 0.79
Is the dopaminergic mesocorticolimbic system necessary for intracranial self-stimulation? Biochemical and behavioral studies from A10 cell bodies and terminals. Behav Neural Biol (1979) 0.79
Amphetamine, apomorphine and investigatory behavior in the rat: analysis of the structure and pattern of responses. Psychopharmacology (Berl) (1986) 0.79
Behavioral analysis of the effect of neurotensin injected into the ventral mesencephalon on investigatory and spontaneous motor behavior in the rat. Psychopharmacology (Berl) (1985) 0.78
Antinociceptive effect of taurine and its inhibition by naxolone. Gen Pharmacol (1990) 0.78
Transcutaneous electrical stimulation with Limoge current potentiates morphine analgesia and attenuates opiate abstinence syndrome. Biol Psychiatry (1990) 0.78
Disappearance of hoarding and disorganization of eating behavior after ventral mesencephalic tegmentum lesions in rats. J Comp Physiol Psychol (1978) 0.78
Behavioral analysis of the effect of substance P injected into the ventral mesencephalon on investigatory and spontaneous motor behavior in the rat. Psychopharmacology (Berl) (1985) 0.78
Chronic treatment with five different neuroleptics elicits behavioral supersensitivity to opiate infusion into the nucleus accumbens. Biol Psychiatry (1986) 0.78
Naloxone-induced opiate withdrawal produces long-lasting and context-independent changes in aggressive and social behaviors of postdependent male mice. Behav Neurosci (2000) 0.77
Effects of two alpha 2 agonists, rilmenidine and clonidine, on the morphine withdrawal syndrome and their potential addictive properties in rats. Am J Cardiol (1988) 0.77
A formal total synthesis of the sesterterpenoid (+/-)-dysidiolide and approaches to the syntheses of (+/-)-6-epi-, (+/-)-15-epi-, and (+/-)-6,15-bisepidysidiolide. Org Lett (2000) 0.77
Neuropeptide FLFQRFamide receptors within the ventral mesenchephalon and dopaminergic terminal areas: localization and functional antiopioid involvement. Neuroscience (1995) 0.77
Is cortical dopamine only the precursor of noradrenaline? Br J Pharmacol (1973) 0.77
Amphetamine-induced conditioned activity is insensitive to perturbations known to affect pavlovian conditioned responses in rats. Behav Neurosci (1998) 0.77
Self-stimulation and catecholamines. 3. Effect of imposed or self-stimulation in the area ventralis tegmenti on catecholamine utilization in the rat brain. Brain Res (1973) 0.76
Further evidence of the antiarrhythmic efficacy of taurine in the rat heart. Res Commun Chem Pathol Pharmacol (1984) 0.76
Sleep impairments in rats implanted with morphine pellets. Neuropsychobiology (1999) 0.76
Behavioral sensitization induced by psychostimulants or stress: search for a molecular basis and evidence for a CRF-dependent phenomenon. Ann N Y Acad Sci (1992) 0.76
Dose dependent behavioural stimulation after local infusion of substance P into the ventral tegmental area in the rat [proceedings]. Br J Pharmacol (1979) 0.75
Chronic dopamine antagonism facilitates opiate-induced feeding. J Psychiatry Neurosci (1995) 0.75
Effect of homotaurine in experimental analgesia tests. Gen Pharmacol (1991) 0.75
d-Ala-met-enkephalin injection into the ventral tegmental area: effect on investigatory and spontaneous motor behaviour in the rat. Psychopharmacology (Berl) (1988) 0.75
Changes in cortical and subcortical levels of monoamines and their metabolites following unilateral ventrolateral cortical lesions in the rat. Brain Res (1983) 0.75
Distribution of dopaminergic terminals in rat cerebral cortex: role of dopaminergic mesocortical system in ventral tegmental area syndrome. Adv Biochem Psychopharmacol (1977) 0.75
Enhancement of noradrenaline responses by thyrotropine-releasing hormone. J Pharm Pharmacol (1975) 0.75
Intra-accumbens implants of embryonic dopaminergic neurons reverse the behavioral supersensitivity to opiates evoked by lesion of the mesolimbic dopaminergic pathway. Brain Res (1990) 0.75
A novel long-lasting dopamine receptor blocker: haloperidol-bovine serum albumin conjugate. Eur J Pharmacol (1985) 0.75
Central administration of arginine vasotocin: effects on exploratory behavior in the rat. Psychopharmacology (Berl) (1982) 0.75
6-Hydroxydopamine Lesion of Ventral Tegmental Area Dopaminergic Cell Bodies does not Impair Neuroendocrine Responses to Environmental Stimuli. J Neuroendocrinol (1990) 0.75
Topographical distribution of dopaminergic innervation and dopaminergic receptors of the anterior cerebral cortex of the rat. Brain Res (1978) 0.75
[Interaction between oral anticoagulants and dietary factors]. Harefuah (2000) 0.75
Locomotor hyperactivity and hypoexploration after lesion of the dopaminergic-A10 area in the ventral mesencephalic tegmentum (VMT) of rats. Behav Brain Res (1980) 0.75
[Effects of lesions of the anterior raphe nuclei on the self-administration of d-amphetamine in the rat : considerable increase of desire for the poison]. C R Seances Acad Sci D (1980) 0.75